Product Details
MOXONIDINE 0.2 MG
Introduction : MOXONIDINE 0.2 MG Tablet is a medicine used for the treatment of high blood pressure. It lowers your blood pressure by relaxing your blood vessels and decreasing your heart rate (the number of times the heart beats per minute).
Indication : Hypertension: MOXONIDINE 0.2 MG Tablet is used to treat high blood pressure (hypertension).
MOXONIDINE 0.2 MG Tablet helps lower blood pressure by reducing sympathetic nervous system activity. It acts centrally on the brain to decrease the release of certain neurotransmitters, leading to vasodilation (widening of blood vessels) and a reduction in heart rate.
Administration : Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it.
MOXONIDINE 0.2 MG Tablet is a prescription medicine and should be taken exactly as directed by your doctor. Take it at the same time every day to maintain a constant level of this medicine in your body. Avoid discontinuing the treatment without consulting your doctor, as it may cause withdrawal symptoms (agitation, restlessness, headache, etc).
Storage : store at room temperature away from moisture and heat.
Mechanism of Action : Moxonidine stimulates central alpha-2 adrenergic receptors in the brain, resulting in a reduction of sympathetic nervous system activity. This leads to vasodilation (widening of blood vessels) and a decrease in heart rate, contributing to the lowering of blood pressure.
Therapeutic : Anti Hypertensive agent
Side Effects : MOXONIDINE 0.2 MG Tablet may cause common side effects such as dizziness, nausea/vomiting, fatigue, dry mouth, constipation, etc. These side effects usually subside with time. However, consult your doctor if they persist or worsen.
Contraindications : Contraindicated in individuals with severe liver impairment.
Caution is advised in patients with a history of depression or psychiatric disorders.
Safety Advice / Warnings : Moxonidine 0.3mg Tablet may cause excessive drowsiness with alcohol.
Safety during breastfeeding is not well-established; consult with a healthcare professional.
References : Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (2003). Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension, 42(6), 1206-1252.